ADULT ACUTE MYELOID LEUKEMIA WITHOUT MATURATION
Clinical trials for ADULT ACUTE MYELOID LEUKEMIA WITHOUT MATURATION explained in plain language.
Never miss a new study
Get alerted when new ADULT ACUTE MYELOID LEUKEMIA WITHOUT MATURATION trials appear
Sign up with your email to follow new studies for ADULT ACUTE MYELOID LEUKEMIA WITHOUT MATURATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for older leukemia patients
Disease control OngoingThis study tested a combination of two drugs—azacitidine and gemtuzumab ozogamicin—in 133 adults aged 60 and older with untreated acute myeloid leukemia (AML). The goal was to see how well the treatment could put the cancer into remission and help patients live longer. The approa…
Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITHOUT MATURATION
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New drug combo aims to boost leukemia remission
Disease control OngoingThis study tests whether adding the drug decitabine to standard chemotherapy can help more adults with acute myeloid leukemia (AML) achieve remission. About 178 participants will receive either low or high doses of decitabine alongside chemo drugs. The goal is to see if this appr…
Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITHOUT MATURATION
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC